Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.
By P. Guillou, P. Quirke, H. Thorpe, Joanne Walker, D. Jayne, Adrian Smith, R. Heath, Julia M. Brown. The Lancet, 2005
2,977 citations recorded by the source corpus.
Subfields: Oncology, Pathology and Forensic Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/83e5a18f6ac17ccc9a98ec560712d2e04f647b61
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- H. Katayama
- Y. Kurokawa
- Kenichi Nakamura
- Hiroyuki Ito
- Y. Kanemitsu
- N. Masuda
- Y. Tsubosa
- T. Satoh
Citations in the corpus
- A randomized trial of laparoscopic versus open surgery for rectal cancer. (2015, neutral): “(%) I: healthy 156 (22) 65 (19) II: mild systemic disease 386 (55) 211 (61) III: severe systemic disease 131 (19) 61 (18) IV: severe life-threatening systemic disease 5 (1) 1 (<1)”
- Laparoscopy in Combination with Fast Track Multimodal Management is the Best Perioperative Strategy in Patients Undergoing Colonic Surgery: A Randomized Clinical Trial (LAFA-study) (2011, background): “All patients were discharged if they complied with the following predefined discharge criteria: (1) adequate pain control with paracetamol and/or nonsteroidal antiinflammatory drugs (2) ability to tolerate solid food (3) absence of nausea (4) passage of first flatus and/or first stool (5) mobilizati”
- Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria (2015, methodology): “Few randomized controlled trials (RCTs) [3] have used this classification system, with individual parochial definitions of surgical complications being used in most surgical RCTs [4–6].”